stockportfolio.pro
Stocks / SDGR vs TNDM
SDGR vs TNDM
Schrödinger, Inc. and Tandem Diabetes Care, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Schrödinger, Inc. (SDGR) | Tandem Diabetes Care, Inc. (TNDM) | |
|---|---|---|
| Market cap | $1.1B | $1.1B |
| Revenue (latest FY) | $255.87M | $1.01B |
| Net income (latest FY) | $-103.27M | $-204.71M |
| Revenue growth (5y CAGR) | 18.8% | 15.3% |
| Net margin | -40.4% | -20.2% |
| Return on equity | -28.4% | -131.9% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 1 | 1 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open SDGR — free Open TNDM — freeFrequently asked questions
Which is bigger, SDGR or TNDM?
Tandem Diabetes Care, Inc. is larger by market capitalization — $1.1B versus $1.1B.
Which grows faster, SDGR or TNDM?
Over the last five fiscal years, Schrödinger, Inc. grew revenue faster — 18.8%/yr versus 15.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.